{"id":91120,"date":"2026-05-19T18:18:14","date_gmt":"2026-05-19T12:48:14","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=91120"},"modified":"2026-05-19T18:18:15","modified_gmt":"2026-05-19T12:48:15","slug":"rainbow-childrens-medicare-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/","title":{"rendered":"Rainbow Childrens Medicare Analyst Review May 2026"},"content":{"rendered":"<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/rainbow\/rainbow-children's-medicare-ltd-share-price-today\">Rainbow Childrens Medicare<\/a> analyst review<\/strong> for May 2026 covers the key data investors need for RAINBOW at its current price of Rs 1,339.00. Rainbow Childrens Medicare (NSE: RAINBOW) is India&#8217;s largest paediatric hospital chain with a market capitalisation of approximately Rs 8,500 crore, operating 15 hospitals focused on children and women&#8217;s health. The analyst consensus target of Rs 1,800 implies meaningful upside, and this <strong>Rainbow Childrens Medicare analyst review<\/strong> examines technical levels, business segments, valuation, and key risks for RAINBOW through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Rainbow_Childrens_Medicare_Company_Snapshot_May_2026\" title=\"Rainbow Childrens Medicare Company Snapshot May 2026\">Rainbow Childrens Medicare Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Analyst_Insight_in_This_Rainbow_Childrens_Medicare_Analyst_Review\" title=\"Analyst Insight in This Rainbow Childrens Medicare Analyst Review\">Analyst Insight in This Rainbow Childrens Medicare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Technical_Analysis_in_This_Rainbow_Childrens_Medicare_Analyst_Review\" title=\"Technical Analysis in This Rainbow Childrens Medicare Analyst Review\">Technical Analysis in This Rainbow Childrens Medicare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Key_Support_and_Resistance_Levels\" title=\"Key Support and Resistance Levels\">Key Support and Resistance Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Business_Segment_Analysis\" title=\"Business Segment Analysis\">Business Segment Analysis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Paediatric_Hospitals_NICU_Cardiac_Surgery\" title=\"Paediatric Hospitals (NICU, Cardiac Surgery)\">Paediatric Hospitals (NICU, Cardiac Surgery)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Women_and_Mother-Child_Health_Services\" title=\"Women and Mother-Child Health Services\">Women and Mother-Child Health Services<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Fertility_and_Reproductive_Medicine\" title=\"Fertility and Reproductive Medicine\">Fertility and Reproductive Medicine<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Valuation_in_This_Rainbow_Childrens_Medicare_Analyst_Review\" title=\"Valuation in This Rainbow Childrens Medicare Analyst Review\">Valuation in This Rainbow Childrens Medicare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Trade_Outlook_for_Rainbow_Childrens_Medicare\" title=\"Trade Outlook for Rainbow Childrens Medicare\">Trade Outlook for Rainbow Childrens Medicare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Key_Risks_for_Rainbow_Childrens_Medicare_in_FY27\" title=\"Key Risks for Rainbow Childrens Medicare in FY27\">Key Risks for Rainbow Childrens Medicare in FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Conclusion_Rainbow_Childrens_Medicare_Analyst_Review_Verdict_for_2026\" title=\"Conclusion: Rainbow Childrens Medicare Analyst Review Verdict for 2026\">Conclusion: Rainbow Childrens Medicare Analyst Review Verdict for 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Frequently_Asked_Questions_Rainbow_Childrens_Medicare_Analyst_Review_2026\" title=\"Frequently Asked Questions: Rainbow Childrens Medicare Analyst Review 2026\">Frequently Asked Questions: Rainbow Childrens Medicare Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#What_is_the_analyst_target_for_Rainbow_Childrens_Medicare_in_2026\" title=\"What is the analyst target for Rainbow Childrens Medicare in 2026?\">What is the analyst target for Rainbow Childrens Medicare in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Is_Rainbow_Childrens_Medicare_a_good_investment_at_Rs_133900\" title=\"Is Rainbow Childrens Medicare a good investment at Rs 1,339.00?\">Is Rainbow Childrens Medicare a good investment at Rs 1,339.00?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#What_is_Rainbow_Childrens_Medicares_52-week_high_and_low\" title=\"What is Rainbow Childrens Medicare&#8217;s 52-week high and low?\">What is Rainbow Childrens Medicare&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#What_are_the_key_risks_for_Rainbow_Childrens_Medicare\" title=\"What are the key risks for Rainbow Childrens Medicare?\">What are the key risks for Rainbow Childrens Medicare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-childrens-medicare-analyst-review-2026\/#Where_can_I_track_live_data_for_Rainbow_Childrens_Medicare\" title=\"Where can I track live data for Rainbow Childrens Medicare?\">Where can I track live data for Rainbow Childrens Medicare?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Rainbow_Childrens_Medicare_Company_Snapshot_May_2026\"><\/span><strong>Rainbow Childrens Medicare Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rainbow&#8217;s paediatric specialisation in neonatal intensive care, paediatric cardiac surgery, and paediatric oncology creates a distinct clinical moat. The company is expanding into Tier 2 cities and adding fertility and obstetrics. The table below summarises the key data referenced in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>RAINBOW<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Healthcare &#8211; Paediatric Hospitals<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 1,339.00<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,645.70<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 1,084.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 8,500 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>55x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 1,800<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 2,200<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 1,300<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_in_This_Rainbow_Childrens_Medicare_Analyst_Review\"><\/span><strong>Analyst Insight in This Rainbow Childrens Medicare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Senior Research Analyst <strong>Ankit Jaiswal<\/strong> flags Rainbow Childrens Medicare as a stock to watch in May 2026. At Rs 1,339.00, Ankit Jaiswal identifies key support in the Rs 1106 to Rs 1272 band and resistance near Rs 1419. He suggests watching Rainbow Childrens Medicare for a potential move toward Rs 1,800, subject to Healthcare &#8211; Paediatric Hospitals sector momentum and Nifty 50 direction. Ankit Jaiswal&#8217;s view is one input in this <strong>Rainbow Childrens Medicare analyst review<\/strong> and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Rainbow_Childrens_Medicare_Analyst_Review\"><\/span><strong>Technical Analysis in This Rainbow Childrens Medicare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 1,339.00, RAINBOW is trading within its 52-week band of Rs 1,084.00 to Rs 1,645.70. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.<\/p>\n<p>Near-term support is identified in the Rs 1106 to Rs 1272 band while resistance is seen in the Rs 1419 to Rs 1570 zone. A sustained move above Rs 1419 could open the path toward the analyst consensus target of Rs 1,800 as outlined in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Support_and_Resistance_Levels\"><\/span><strong>Key Support and Resistance Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 1106 to Rs 1272 &#8211; investors tracking this <strong>Rainbow Childrens Medicare analyst review<\/strong> should watch for stabilisation or a bounce in this range as a potential accumulation signal for RAINBOW.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 1419 to Rs 1570 &#8211; a sustained close above Rs 1419 would be a positive breakout signal worth flagging in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/li>\n<li><strong>Medium-Term Target:<\/strong> The analyst consensus of Rs 1,800 represents the base-case upside scenario in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segment_Analysis\"><\/span><strong>Business Segment Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Paediatric_Hospitals_NICU_Cardiac_Surgery\"><\/span><strong>Paediatric Hospitals (NICU, Cardiac Surgery)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the primary revenue and margin driver for Rainbow Childrens Medicare, directly supporting the earnings trajectory toward the consensus target of Rs 1,800.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Women_and_Mother-Child_Health_Services\"><\/span><strong>Women and Mother-Child Health Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds scale and diversification to Rainbow Childrens Medicare&#8217;s business model and is a meaningful EPS contributor through FY27 and FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Fertility_and_Reproductive_Medicine\"><\/span><strong>Fertility and Reproductive Medicine<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This represents the medium-term growth frontier for Rainbow Childrens Medicare and a key re-rating catalyst over the next 12 to 24 months.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_in_This_Rainbow_Childrens_Medicare_Analyst_Review\"><\/span><strong>Valuation in This Rainbow Childrens Medicare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 1,339.00, Rainbow Childrens Medicare trades at a trailing P\/E of 55x. This <strong>Rainbow Childrens Medicare analyst review<\/strong> presents three scenarios: a bull case of Rs 2,200 on strong earnings delivery and sector tailwinds, a base case of Rs 1,800 at analyst consensus, and a bear case of Rs 1,300 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 2,200<\/td>\n<td>Strong earnings delivery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Consensus)<\/td>\n<td>Rs 1,800<\/td>\n<td>Moderate growth, analyst consensus estimate<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1,300<\/td>\n<td>Earnings miss or macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Trade_Outlook_for_Rainbow_Childrens_Medicare\"><\/span><strong>Trade Outlook for Rainbow Childrens Medicare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the technical and fundamental analysis in this <strong>Rainbow Childrens Medicare analyst review<\/strong>, investors might watch RAINBOW near the support zone of Rs 1106 to Rs 1272 for potential opportunities. A flag above Rs 1419 could suggest improving momentum toward Rs 1,800. This article uses watch-and-flag language only and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Rainbow_Childrens_Medicare_in_FY27\"><\/span><strong>Key Risks for Rainbow Childrens Medicare in FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A well-rounded <strong>Rainbow Childrens Medicare analyst review<\/strong> must assess downside risks. Key risks for Rainbow Childrens Medicare include a macro slowdown affecting Healthcare &#8211; Paediatric Hospitals sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in RAINBOW.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Rainbow_Childrens_Medicare_Analyst_Review_Verdict_for_2026\"><\/span><strong>Conclusion: Rainbow Childrens Medicare Analyst Review Verdict for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Rainbow Childrens Medicare analyst review<\/strong> concludes that at Rs 1,339.00, RAINBOW offers a defined risk-reward with a consensus target of Rs 1,800. The 52-week range of Rs 1,084.00 to Rs 1,645.70 provides context on the current entry point. Use this <strong>Rainbow Childrens Medicare analyst review<\/strong> as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on RAINBOW.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_Rainbow_Childrens_Medicare_Analyst_Review_2026\"><\/span><strong>Frequently Asked Questions: Rainbow Childrens Medicare Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Rainbow_Childrens_Medicare_in_2026\"><\/span><strong>What is the analyst target for Rainbow Childrens Medicare in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The analyst consensus target is Rs 1,800, with a bull case of Rs 2,200 and a bear case of Rs 1,300. This <strong>Rainbow Childrens Medicare analyst review<\/strong> recommends monitoring Q1 FY27 earnings for confirmation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Rainbow_Childrens_Medicare_a_good_investment_at_Rs_133900\"><\/span><strong>Is Rainbow Childrens Medicare a good investment at Rs 1,339.00?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 1,339.00 with a P\/E of 55x and a consensus target of Rs 1,800, this <strong>Rainbow Childrens Medicare analyst review<\/strong> is constructive for medium to long-term investors in the Healthcare &#8211; Paediatric Hospitals sector. Always consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Rainbow_Childrens_Medicares_52-week_high_and_low\"><\/span><strong>What is Rainbow Childrens Medicare&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52-week high is Rs 1,645.70 and the 52-week low is Rs 1,084.00. At Rs 1,339.00, RAINBOW is positioned within this range as detailed in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Rainbow_Childrens_Medicare\"><\/span><strong>What are the key risks for Rainbow Childrens Medicare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Healthcare &#8211; Paediatric Hospitals sector, all assessed in this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Rainbow_Childrens_Medicare\"><\/span><strong>Where can I track live data for Rainbow Childrens Medicare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Rainbow Childrens Medicare&#8217;s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this <strong>Rainbow Childrens Medicare analyst review<\/strong>.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rainbow Childrens Medicare analyst review 2026: CMP Rs 1,339.00, MCap Rs 8,500 Cr, PE 55x. Healthcare &#8211; Paediatric Hospitals sector technical levels. May 2026.<\/p>\n","protected":false},"author":28,"featured_media":91863,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-91120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779194898:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Rainbow Childrens Medicare Analyst Review 2026"],"rank_math_description":["Rainbow Childrens Medicare analyst review 2026: CMP Rs 1,339.00, MCap Rs 8,500 Cr, PE 55x. Healthcare - Paediatric Hospitals sector technical levels. May 2026."],"rank_math_focus_keyword":["Rainbow Childrens Medicare Analyst Review"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["91863"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12368"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/19181757\/Rainbow-Childrens-Medicare-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=91120"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91120\/revisions"}],"predecessor-version":[{"id":91864,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91120\/revisions\/91864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/91863"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=91120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=91120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=91120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}